Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease
Madhumita Basu, Jun-Yi Zhu, Stephanie LaHaye, Uddalak Majumdar, Kai Jiao, Zhe Han, Vidu Garg
Madhumita Basu, Jun-Yi Zhu, Stephanie LaHaye, Uddalak Majumdar, Kai Jiao, Zhe Han, Vidu Garg
View: Text | PDF
Research Article Cardiology Genetics

Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease

  • Text
  • PDF
Abstract

Birth defects are the leading cause of infant mortality, and they are caused by a combination of genetic and environmental factors. Environmental risk factors may contribute to birth defects in genetically susceptible infants by altering critical molecular pathways during embryogenesis, but experimental evidence for gene-environment interactions is limited. Fetal hyperglycemia associated with maternal diabetes results in a 5-fold increased risk of congenital heart disease (CHD), but the molecular basis for this correlation is unknown. Here, we show that the effects of maternal hyperglycemia on cardiac development are sensitized by haploinsufficiency of Notch1, a key transcriptional regulator known to cause CHD. Using ATAC-seq, we found that hyperglycemia decreased chromatin accessibility at the endothelial NO synthase (Nos3) locus, resulting in reduced NO synthesis. Transcription of Jarid2, a regulator of histone methyltransferase complexes, was increased in response to reduced NO, and this upregulation directly resulted in inhibition of Notch1 expression to levels below a threshold necessary for normal heart development. We extended these findings using a Drosophila maternal diabetic model that revealed the evolutionary conservation of this interaction and the Jarid2-mediated mechanism. These findings identify a gene-environment interaction between maternal hyperglycemia and Notch signaling and support a model in which environmental factors cause birth defects in genetically susceptible infants.

Authors

Madhumita Basu, Jun-Yi Zhu, Stephanie LaHaye, Uddalak Majumdar, Kai Jiao, Zhe Han, Vidu Garg

×

Figure 4

Jarid2 mediated regulation of Notch1 with hyperglycemia.

Options: View larger image (or click on image) Download as PowerPoint
Jarid2 mediated regulation of Notch1 with hyperglycemia.
(A) RT-qPCR and...
(A) RT-qPCR and (B) representative immunoblot showing Jarid2 transcript and JARID2 protein levels in NG- (5.5 mM) and HG-treated (25 mM) AVM cells 24 and 48 hours after treatment (n = 4; mean ± SEM; *P < 0.05, 2-tailed Student’s t test). (C) Quantification of relative expression normalized to GAPDH (n = 4; mean ± SEM; *P < 0.05, 2-tailed Student’s t test). (D) Examination of E13.5 murine hearts (n = 6 hearts pooled together/group) exposed to nondiabetic and diabetic environments shows upregulation of Jarid2 mRNA by RT-qPCR (mean ± SD; *P < 0.05, 2-tailed Student’s t test). (E and F) Increased JARID2 protein in embryonic hearts exposed to maternal diabetes by immunohistochemistry (n = 3). Square boxes in E and F are shown in higher magnification from left to right. LV, left ventricle; RV, right ventricle; IVS, interventricular septum. Scale bars: 100 μm (E and F, left column); 20 μm (E and F, center and right columns). (G) ChIP-qPCR on AVM cells in NG or HG revealed enrichment of JARID2 on Notch1+1150 locus with HG and lack of enrichment with addition of 250 μM DetaNONOate (n = 4; mean ± SEM; #P < 0.05, 2-tailed Student’s t test, not significant with Holm-Bonferroni correction). (H) In vivo ChIP-qPCR on E13.5 hearts exposed to nondiabetic and diabetic environments (n = 3). Rabbit IgG served as mock control, shown as dotted line (set to 1) (mean ± SEM; *P < 0.05, 2-tailed Student’s t test).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts